Rad AI raised its Series C funding to $68 million, with $8 million from top U.S. health systems.
Key Details
- 1Advocate Health, Memorial Hermann, Corewell Health, and Atlantic Health System invested a combined $8 million.
- 2The total fundraising for Rad AI's Series C is $68 million.
- 3Rad AI's solutions reportedly impact nearly half of all imaging volumes in the U.S.
- 4The company achieved 8,710% revenue growth from 2020-2023.
- 5Rad AI is valued at $525 million according to Pitchbook estimates.
- 6The investment aims to drive systemwide adoption of radiology AI and address clinical and operational pressures.
Why It Matters
Such large-scale investment by major health systems signals growing confidence in radiology-focused AI solutions and supports further innovation and adoption. This collaboration could accelerate AI integration across the imaging workflow, with potential improvements in patient care and operational efficiency.
Source
Radiology Business
Related News
•Radiology Business
NVIDIA Envisions Autonomous AI Agents Transforming Radiology
NVIDIA foresees a major shift in radiology toward autonomous AI agents and imaging systems that could revolutionize patient care.
•Radiology Business
FDA-Cleared Imaging AI Proliferates, But Reimbursement Stalls
Despite a surge in FDA-cleared radiology AI tools, very few qualify for reimbursement due to lack of supporting clinical studies.
•Radiology Business
FDA Approves 56 New AI Radiology Devices, Total Tops 1,000
FDA updates its list with 56 new AI-powered radiology devices, bringing the total to over 1,000 approved tools.